[VEGF121 expression and angioneogenesis in lung cancer].
Ota
Y
Y
Shimizu
J
J
Oda
M
M
Hayashi
Y
Y
Kure
T
T
Nagatoshi
A
A
Tabata
T
T
Watanabe
Y
Y
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D003510:Cyclohexanes; D016228:Endothelial Growth Factors / Q000032:analysis*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D008207:Lymphatic Metastasis / Q000517:prevention & control; D008222:Lymphokines / Q000032:analysis*; D051379:Mice; D008819:Mice, Nude; D009389:Neovascularization, Pathologic; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D012717:Sesquiterpenes / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000903:Antibiotics, Antineoplastic; D003510:Cyclohexanes; D016228:Endothelial Growth Factors; D008222:Lymphokines; D012717:Sesquiterpenes; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000077609:O-(Chloroacetylcarbamoyl)fumagillol